Stephen M. McLean

Partner
Arsenal Capital Partners

Steve McLean was a founding member and has served as Chairman of the Board of the International Biomedical Research Alliance since 2005.

Mr. McLean is a Senior Partner of Arsenal Capital Partners. Arsenal is a private equity fund that manages approximately $8 billion of equity capital. Mr. McLean is the Chairman of Arsenal’s Healthcare Group which focuses on investments in companies that improve the efficacy of pharmaceutical and bio-tech research and development, hospital and provider operations. Prior to joining Arsenal, Mr. McLean was a life science investor who co-founded HIT and genomics companies such as CentriHealth, Agencourt Bioscience, and Agencourt Personal Genomics.

Previously, Mr. McLean was a founding partner of Merrill Lynch Capital Partners (and successor funds) which was a leader in the development of the leveraged buyout industry.

Mr. McLean graduated with a B.S. in Economics, summa cum laude, from the Wharton School of the University of Pennsylvania and received an M.B.A., with distinction, from the Wharton School of the University of Pennsylvania. He currently serves on the board of directors of Accumen, CellCarta, Certara, and WCG Clinical.

Mr. McLean and his wife reside in New Jersey and have three children and seven grandchildren.